<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">37524570</PMID><DateRevised><Year>2023</Year><Month>09</Month><Day>30</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1879-114X</ISSN><JournalIssue CitedMedium="Internet"><Volume>45</Volume><Issue>9</Issue><PubDate><Year>2023</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Clinical therapeutics</Title><ISOAbbreviation>Clin Ther</ISOAbbreviation></Journal><ArticleTitle>Long COVID-19 and Insulin Autoimmune Syndrome: A Case Report.</ArticleTitle><Pagination><StartPage>e187</StartPage><EndPage>e192</EndPage><MedlinePgn>e187-e192</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.clinthera.2023.06.026</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0149-2918(23)00250-3</ELocationID><Abstract><AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">To describe a case report of a patient with symptoms associated with metabolic alterations 1 month after having COVID-19.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Laboratory tests, clinical evaluations, and body composition assessments were performed by specialists.</AbstractText><AbstractText Label="FINDINGS" NlmCategory="RESULTS">The patient presented excessive sweating, hot flashes, dizziness, blurred vision, and seizure. Laboratory tests indicated low glucose levels after convulsions (50, 42.7, and 55 mg/dL), high insulin levels (basal, 638 &#xb5;IU/mL; 2-hour, &gt;1000 &#xb5;U/mL), and positivity for anti-insulin antibodies. The patient was diagnosed with insulin autoimmune syndrome. Treatment with azathioprine and nutritional recommendations improved remission.</AbstractText><AbstractText Label="IMPLICATIONS" NlmCategory="CONCLUSIONS">SARS-CoV-2 infection or vaccination might induce insulin tolerance failure.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Corona-Meraz</LastName><ForeName>Fernanda Isadora</ForeName><Initials>FI</Initials><AffiliationInfo><Affiliation>Departamento de Ciencias Biom&#xe9;dicas, Centro Universitario de Tonal&#xe1;, Universidad de Guadalajara, Guadalajara, M&#xe9;xico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Quintero-Castillo</LastName><ForeName>Blanca Perla</ForeName><Initials>BP</Initials><AffiliationInfo><Affiliation>Unidad de Especialidades, Cl&#xed;nica Ambulatoria, Guadalajara, M&#xe9;xico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hern&#xe1;ndez-Palma</LastName><ForeName>Luis Alexis</ForeName><Initials>LA</Initials><AffiliationInfo><Affiliation>Instituto de Investigaciones en Comportamiento Alimentario y Nutrici&#xf3;n, Centro Universitario del Sur, Universidad de Guadalajara, Guadalajara, M&#xe9;xico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Machado-Sulbaran</LastName><ForeName>Andrea Carolina</ForeName><Initials>AC</Initials><AffiliationInfo><Affiliation>Instituto de Investigaci&#xf3;n en C&#xe1;ncer en la Infancia y Adolescencia, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Guadalajara, M&#xe9;xico. Electronic address: andrecaroms@gmail.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D002363">Case Reports</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>07</Month><Day>29</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Clin Ther</MedlineTA><NlmUniqueID>7706726</NlmUniqueID><ISSNLinking>0149-2918</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Autoimmunity</Keyword><Keyword MajorTopicYN="N">Azathioprine</Keyword><Keyword MajorTopicYN="N">Insulin</Keyword><Keyword MajorTopicYN="N">Long COVID-19</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword></KeywordList><CoiStatement>Declaration of Competing Interest The authors have indicated that they have no conflicts of interest with regard to the content of this article.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>3</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>6</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>6</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>8</Month><Day>1</Day><Hour>1</Hour><Minute>8</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>8</Month><Day>1</Day><Hour>1</Hour><Minute>8</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>7</Month><Day>31</Day><Hour>21</Hour><Minute>52</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37524570</ArticleId><ArticleId IdType="doi">10.1016/j.clinthera.2023.06.026</ArticleId><ArticleId IdType="pii">S0149-2918(23)00250-3</ArticleId></ArticleIdList></PubmedData></PubmedArticle></PubmedArticleSet>